Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias
- PMID: 33097982
- PMCID: PMC7646199
- DOI: 10.1007/s11906-020-01111-8
Stellate Ganglion Blockade: an Intervention for the Management of Ventricular Arrhythmias
Abstract
Purpose of review: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias.
Recent findings: In patients with refractory ventricular arrhythmias, unilateral or bilateral SGB can reduce arrhythmia burden and defibrillation events for 24-72 h, allowing time for use of other therapies like catheter ablation, surgical sympathectomy, or heart transplantation. The efficacy of SGB appears to be consistent despite the type (monomorphic vs polymorphic) or etiology (ischemic vs non-ischemic cardiomyopathy) of the ventricular arrhythmia. Ultrasound-guided SGB is safe with low risk for complications, even when performed on anticoagulation. SGB is effective and safe and could be considered for patients with refractory ventricular arrhythmias.
Keywords: Stellate ganglion block; Ventricular arrhythmia; Ventricular fibrillation; Ventricular tachycardia.
Conflict of interest statement
Figures




References
-
- Pokorney SD, Mi X, Hammill BG, Allen LaPointe NM, Curtis LH, Al-Khatib SM. Use of antiarrhythmic medications in Medicare part D patients with an implantable cardioverterdefibrillator and ventricular tachycardia. Am J Cardiol. 2017;119(9):1401–6. - PubMed
-
- Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation. 2001;104(18): 2158–63. - PubMed
-
- Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM. Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation. 2000;102(7): 742–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials